This compound belongs to the class of organic compounds known as o-hydroxybenzoic acid esters. These are benzoic acid esters where the benzene ring is ortho-substituted with a hydroxy group.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
Peso molecolare
299.160 g/mol
XLogP3
5.400
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
3
Exact Mass
298.02 Da
Monoisotopic Mass
298.02 Da
Topological Polar Surface Area
46.500 Ų
Heavy Atom Count
17
Formal Charge
0
Complexity
263.000
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
The total count of all stereochemical bonds
0
Covalently-Bonded Unit Count
1
Calcolatori di soluzioni
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Recensioni
Recensioni dei clienti
Application Protocols
No assay-specific protocols (e.g., WB, IHC, IF, FC) apply to this small-molecule building block. For synthetic applications, see the Reaction Conditions section. For use as a substrate/intermediate, follow standard organic synthesis and purification practices (dry/inert techniques for air/moisture-sensitive steps, chromatographic purification, and spectroscopic verification).
Biological Roles
Item-specific biological data: Not specified for this item; refer to literature if needed.
General context (no clinical/therapeutic claims)
The molecule is a synthetic salicylate derivative featuring a phenolic OH and an aryl bromide. It is not known as a natural metabolite.
Salicylate motifs (2-hydroxybenzoates) are prevalent in natural products and metal-chelating ligands due to the ortho-hydroxy–carbonyl arrangement that can form six-membered chelates with many metal ions. This intramolecular H-bonding also modulates acidity and lipophilicity.
As a research building block, derivatives may be explored in biochemical probe development or as intermediates toward ligands for metalloenzymes or coordination complexes; however, any biological evaluation is project-specific and outside the scope of this listing.
The cyclohexyl ester increases hydrophobicity versus the parent acid, potentially improving membrane partitioning for probe delivery in cell-based studies; such use requires dedicated optimization and safety assessment.
Buffer Applications
This compound is not a buffering agent and lacks a conjugate acid/base pair suitable for maintaining pH in aqueous systems. It is poorly water-soluble and is not typically used to prepare biochemical buffers. For aqueous experimental contexts, dissolve in a miscible organic co-solvent (e.g., DMSO) before dilution if absolutely necessary, or select a true buffer system appropriate to the pH range of interest (e.g., phosphate, Tris, HEPES).
Green Alternatives
Greener choices focus on solvent and catalyst systems rather than on the substrate itself.
Solvent substitutions (literature guidance)
Replace dichloromethane/chloroform with ethyl acetate or dimethyl carbonate for dissolution and workups when feasible.
Substitute THF with 2-MeTHF or CPME in cross-couplings and O-alkylations; these offer lower peroxide concerns and preferable life-cycle metrics.
Use aqueous micellar media (e.g., TPGS-750-M) for Pd-catalyzed Suzuki couplings at room temperature when boron partners and bases are compatible.
Catalyst/conditions
Employ ligand-optimized Pd systems that operate at lower loadings (≤0.1–0.5 mol%) and in water-rich media to reduce metal and solvent footprints.
Consider nickel catalysis for certain couplings to reduce reliance on Pd; balance against substrate sensitivity and selectivity.
Comparison snapshot (general)
DCM vs EtOAc: EtOAc is biodegradable, lower toxicity; may require higher volumes due to solubility differences.
THF vs 2-MeTHF: 2-MeTHF derived from renewables, better partitioning for extractions; note higher boiling point and potential for phase behavior differences.
DMF/DMAc vs Cyrene or PC (propylene carbonate): greener polar aprotics; verify substrate solubility and base compatibility.
Trade-offs
Greener solvents can alter rates/selectivity; small-scale scouting is recommended. Ensure downstream analytics (e.g., residual solvent specs) align with project requirements.
Pharmaceutical Uses
Item-specific pharmacopeial status: Not specified for this item; refer to CoA/Spec Sheet.
General notes (no therapeutic claims)
As an aryl salicylate bearing an aryl bromide, this compound is best viewed as a synthetic intermediate for discovery and process chemistry rather than as an excipient or formulated component.
Potential roles in pharmaceutical R&D include:
Scaffold for SAR exploration around salicylate motifs, with C5 diversification via cross-coupling.
Protected form of 5-bromo-2-hydroxybenzoic acid, where the cyclohexyl ester can be removed under controlled saponification to unveil the acid late in a sequence.
Precursor to ligand frameworks (e.g., salicylaldimine-type ligands after formylation and condensation), useful in asymmetric catalysis development.
Any use in GMP or clinical manufacturing would require full qualification (impurity profile, residual solvents, elemental impurities) and adherence to ICH guidelines; no such claims are made for this catalog item.
Physical Properties
Item-specific specifications
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Purity/Grade: Not specified for this item; refer to CoA/Spec Sheet.
UV cutoff, residual metals, water/peroxide content: Not specified for this item; refer to CoA/Spec Sheet.
Literature/computed (reference values; not product specifications)
Molecular weight: ~299.16 g/mol (computed from C13H15BrO3)
Expected physical state: crystalline solid or low-melting solid (typical for aryl salicylate esters with Br); exact MP not located in common databases.
Boiling point: Not readily reported; thermal decomposition likely precedes boiling under ambient pressure for many aryl esters (literature generality).
Density: Not located.
LogP: Likely moderate to high lipophilicity due to cyclohexyl ester and aryl bromide; quantitative value not located.
Solubility: Poorly soluble in water (expected for aryl esters); soluble in common organic solvents such as dichloromethane, chloroform, ethyl acetate, THF, acetone; sparingly to moderately soluble in alcohols. Exact solubilities not located.
Acid-base properties: Contains a phenolic OH (weakly acidic; pKa typically ~9–11 for salicylates, literature generality). The carboxyl functionality is esterified (non-ionizable under neutral conditions).
Spectroscopic notes (literature expectations): IR ν≈ 1735–1715 cm−1 (ester C=O), 3200–3600 cm−1 (phenolic O–H, often intramolecularly H-bonded in salicylates), aromatic C–H stretches ~3050 cm−1, Ar–Br absorptions in fingerprint region. Distinct 1H NMR phenolic OH often downfield (δ 10–12) due to intramolecular H-bonding; aryl proton pattern consistent with 1,2,5-trisubstitution.
Quality and Grades
Item-specific quality information
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Stabilizers/Inhibitors: Not specified for this item; refer to CoA/Spec Sheet.
Interpreting grades (general guidance)
Research-grade small-molecule building blocks are typically provided at high chemical purity sufficient for synthetic and analytical work. When a specific assay purity (e.g., ≥98%) or chromatographic purity is stated on the CoA, it reflects validated analytical methods (commonly HPLC/GC/1H NMR).
If an “HPLC-grade” or “chromatography-grade” solvent designation appears (not applicable here unless supplied as a solution), it implies minimized UV-absorbing impurities and low residue on evaporation.
Absence/presence of stabilizers: Phenolic salicylate esters generally do not require radical inhibitors; if any stabilizer is used, it will be listed on the CoA. Use of stabilizers may influence downstream polymerization or radical chemistry.
Batch-specific documentation
For exact purity, residual solvents, metal content, and analytical spectra (1H/13C NMR, LC-MS, IR), consult the batch CoA/Spec Sheet. These documents also define acceptance criteria, analytical methods, and storage/handling notes specific to the lot you receive.
Reaction and Applications
As a 5-brominated salicylate ester, this molecule is a versatile bifunctional building block offering orthogonal reactivity at the aryl bromide, the phenolic OH, and the ester linkage.
Aryl bromide transformations (literature)
Suzuki–Miyaura coupling: introduction of (hetero)aryl or vinyl groups at C5 using Pd catalysts (e.g., Pd(PPh3)4 or Pd-PEPPSI variants) with bases such as K2CO3, K3PO4, or Cs2CO3 in dioxane/H2O or toluene/H2O.
Buchwald–Hartwig amination: installation of anilines/anilides at C5 using Pd2(dba)3 or Pd(OAc)2 with BINAP/XPhos/BrettPhos ligands; bases such as NaOtBu in toluene or dioxane.
Direct lithiation/Br–Li exchange: i-PrMgCl•LiCl (Turbo Grignard) or n-BuLi at low temperature to form arylmetals for subsequent electrophile trapping (requires careful control to avoid deprotonation of phenol—protecting the OH as silyl ether or carbonate is beneficial).
Phenolic OH transformations
Selective O-alkylation/acylation to modulate electronics/solubility; carbonate or silyl protection (TBS/TIPS) to guide site-selective metalation or cross-coupling.
Intramolecular H-bonding typical of salicylates can influence acidity and rates; bases like K2CO3/Cs2CO3 in acetone/DMF often suffice for O-alkylation.
Ester linkage utility
Cyclohexyl ester functions as a removable protecting group for the carboxylate: saponify under basic aqueous conditions (NaOH, KOH) or transesterify under acid catalysis to access the acid or alternate esters.
Application contexts
Late-stage diversification of salicylate scaffolds for SAR studies.
Intermediate toward functional materials or ligands where ortho-hydroxybenzoate chelation is advantageous.
Reaction Conditions
The following are literature-style general conditions suitable for compounds of this class; they are not item-specific specifications.
Suzuki–Miyaura coupling at C5–Br
Catalyst: 1–3 mol% Pd(PPh3)4 or Pd2(dba)3 (1 mol% Pd) with XPhos/SPhos (2–5 mol%).
Base: K3PO4 (2–3 equiv) or K2CO3 (2–3 equiv).
Solvent: 1,4-dioxane/H2O (4:1) or toluene/H2O; 80–100 °C; 2–12 h.
Notes: Protect or neutralize the phenolic OH if it poisons the catalyst; addition of TBAB or phase-transfer agents can accelerate reactions.
Buchwald–Hartwig amination
Catalyst/ligand: Pd(OAc)2 (1–2 mol%) with BrettPhos or DavePhos (2–4 mol%); base NaOtBu (2–3 equiv).
Solvent: toluene or dioxane; 80–110 °C; 4–16 h.
Notes: Phenol protection (e.g., TBS) can improve yields with hindered amines.
Br–Li or Br–Mg exchange (electrophile trapping)
Reagents: n-BuLi (1.1 equiv) in THF at −78 to −40 °C; or i-PrMgCl•LiCl in THF at −30 to 0 °C.
Notes: Phenolic OH should be protected or pre-deprotonated/complexed; quench with CO2, DMF, electrophiles as desired.
Conditions: Aqueous NaOH or KOH (1–2 M) in MeOH/H2O or THF/H2O; 25–60 °C; 1–6 h; then acidify to pH ~2.
Notes: Maintain temperature control to avoid competing ether cleavage if phenol is protected.
Safety and Handling
Item-specific hazard data
Signal Word: Not specified for this item; refer to SDS.
H-Statements / GHS Classification / Pictograms: Not specified for this item; refer to SDS.
General laboratory safety guidance (literature/general; not a substitute for SDS)
Likely hazards: Irritation to skin, eyes, and respiratory tract is plausible for aryl esters and phenolic compounds. Avoid inhalation of dust and contact with skin/eyes.
PPE: Wear lab coat, safety glasses or goggles, and appropriate chemical-resistant gloves (e.g., nitrile). Handle in a fume hood to minimize exposure to dust/vapors.
Incompatibilities: Strong bases (risk of ester saponification); strong acids (acid-catalyzed transesterification/hydrolysis); strong oxidizers; reactive metals for aryl halides under metal–halogen exchange conditions.
Thermal/chemical stability: Aromatic esters are generally stable under ambient conditions; avoid prolonged heating in the presence of base or moisture to prevent hydrolysis. No known tendency for peroxide formation (non-ether).
First aid overview: If on skin, wash with soap and water. If in eyes, rinse cautiously with water for several minutes and seek medical advice. If inhaled, move to fresh air; if symptoms persist, seek medical attention. If swallowed, rinse mouth—do not induce vomiting; obtain medical attention.
Spill/cleanup: Avoid dust generation. Collect solids with minimal dusting; for solutions, absorb with inert material. Dispose of in accordance with local regulations.
Always consult the product SDS for authoritative hazard classifications and response measures.
Solvent Selection
This compound is a moderately lipophilic aryl ester with a phenolic OH and an aryl bromide. It is expected to be essentially insoluble in water but soluble in a range of organic solvents.
Good solubility: dichloromethane, chloroform, ethyl acetate, acetone, THF, toluene, DMF/DMSO.
Moderate solubility: alcohols (MeOH, EtOH, i-PrOH) depending on temperature and presence of base.
Poor solubility: water and highly nonpolar alkanes (hexanes) unless warmed or with co-solvent.
Selection by application
Cross-coupling at the aryl bromide: dioxane, toluene, THF, or DMAc/DMF are common; addition of water can aid base solubility for Suzuki reactions.
O-alkylation or acylation of the phenol: polar aprotic solvents (acetone, acetonitrile, DMF) with mild inorganic base (K2CO3, Cs2CO3) are typical.
Hydrolysis/transesterification: alcoholic solvents (MeOH/EtOH) with acid/base catalysis; or aqueous base in THF/MeOH co-solvent.
Comparison notes
Versus highly nonpolar aromatics (toluene), chlorinated solvents (DCM) often give faster dissolution at room temperature.
For greener profiles, consider EtOAc or 2-MeTHF instead of DCM/THF where compatible (see Green Alternatives).
Storage and Reconstitution
Item-specific storage/shipping
Storage Conditions: Room temperature (per Product Data). Store tightly closed in a dry, well-ventilated place away from incompatible reagents (strong acids/bases, oxidizers).
Shipped In: Not specified for this item; refer to CoA/Spec Sheet.
General handling recommendations
Protect from prolonged exposure to light and moisture to minimize slow hydrolysis of the ester and oxidation of the phenolic function.
After opening, consider storing under inert gas with desiccant to extend shelf life, especially in humid environments.
Preparation of solutions (general guidance)
Solvents: Prepare stock solutions in dry organic solvents such as DMSO, DMF, THF, dichloromethane, or ethyl acetate depending on application. For biological testing contexts, DMSO stocks (e.g., 10–100 mM) are common; filter if needed.
Stability in solution: Esters can undergo slow hydrolysis in basic or wet media; prepare fresh solutions for moisture/base-sensitive operations. Refrigerated storage of stock solutions can improve stability, but avoid repeated freeze–thaw cycles; aliquot when practical.
Research Use Note: For research use only (per Product Data).
Structure and Identity
Cyclohexyl 5-bromo-2-hydroxybenzoate is a salicylate-derived aryl bromide bearing a phenolic OH ortho to a benzoate ester and a bromine at the 5-position.
Item-specific (from Product Data)
CAS: 1131587-74-0
InChIKey: 444655
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature/computed identifiers and features (for reference; not product specifications)
Expected molecular formula (based on name): C13H15BrO3 (computed)
Core structural features: benzene ring (1,2-disubstituted, salicylate motif), phenolic hydroxyl at C2, benzoate ester at C1 bearing a cyclohexyl group, aryl bromide at C5.
2D description: A 1,2-disubstituted benzenoid ring where positions 1 and 2 are an ortho pair; position 1 carries a carbonyl carbon of a benzoate linking to an O–cyclohexyl substituent; position 2 is a phenolic OH; position 5 bears bromine; the cyclohexyl ring is a saturated six-membered ring tethered through oxygen.
Stereochemistry: None (all centers achiral; cyclohexyl conformational isomers possible but not configurationally stable).
Synthetic Utility
Orthogonal functional handles
Aryl bromide (C5): gateway to diverse C–C/C–N/C–O bonds via Pd/Ni catalysis (Suzuki, Buchwald–Hartwig, Ullmann-type under copper, or direct metalation).
Phenolic OH (C2): tunable reactivity; protect as carbonate/ether/silyl to direct downstream steps; enables formation of bidentate motifs (salicylate chelates) after further elaboration.
Benzoate ester: cyclohexyl group offers robustness under many coupling conditions yet is cleavable (basic hydrolysis or acid-catalyzed transesterification), functioning as a carboxyl protecting group.
Strategic roles in synthesis
Modular diversification: Install substituents at C5 via cross-coupling, then manipulate the phenolic OH independently to craft libraries of salicylate derivatives.
Late-stage functionalization: Br enables site-selective introduction of sensitive fragments (boronates, stannanes, azoles) under mild cross-coupling.
Access to heteroatom-rich frameworks: Through ortho-quinone methide chemistry from salicylates (after activation), or via electrophilic formylation/oxidation sequences directed by the phenol.
Protecting group logic
Cyclohexyl esters balance stability and removability; compared to methyl/ethyl esters, they may hydrolyze slightly slower under base but show good resistance under neutral coupling conditions, reducing premature deprotection.
Target Specificity
Not applicable. This product is a small-molecule building block, not a biological macromolecule or affinity reagent. No antigen/epitope, clone, isotype, or species reactivity information applies.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.